Home > > > > > Report Detail

Global Celecoxib Market Growth 2020-2025

Publisher Name :
Date: 24-Aug-2020
No. of pages: 135

According to this study, over the next five years the Celecoxib market will register a 8.7%% CAGR in terms of revenue, the global market size will reach $ 1548.5 million by 2025, from $ 1110.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Celecoxib business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Celecoxib market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Celecoxib, covering the supply chain analysis, impact assessment to the Celecoxib market size growth rate in several scenarios, and the measures to be undertaken by Celecoxib companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- 50mg

- 100mg

- 200mg

- 400mg

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Rheumatoid arthritis

- osteoarthritis

- Acute pain

- Musculoskeletal pain

- Other diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Pfizer Inc

- Teva

- Apotex

- Lupin

- Mylan

- Hengrui Medicine

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Celecoxib consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Celecoxib market by identifying its various subsegments.

- Focuses on the key global Celecoxib manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Celecoxib with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Celecoxib submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Celecoxib Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Celecoxib Consumption 2015-2025
2.1.2 Celecoxib Consumption CAGR by Region
2.2 Celecoxib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Consumption by Type
2.3.1 Global Celecoxib Consumption Market Share by Type (2015-2020)
2.3.2 Global Celecoxib Revenue and Market Share by Type (2015-2020)
2.3.3 Global Celecoxib Sale Price by Type (2015-2020)
2.4 Celecoxib Segment by Application
2.4.1 Rheumatoid arthritis
2.4.2 osteoarthritis
2.4.3 Acute pain
2.4.4 Musculoskeletal pain
2.4.5 Other diseases
2.5 Celecoxib Consumption by Application
2.5.1 Global Celecoxib Consumption Market Share by Type (2015-2020)
2.5.2 Global Celecoxib Value and Market Share by Type (2015-2020)
2.5.3 Global Celecoxib Sale Price by Type (2015-2020)

3 Global Celecoxib by Company
3.1 Global Celecoxib Sales Market Share by Company
3.1.1 Global Celecoxib Sales by Company (2018-2020)
3.1.2 Global Celecoxib Sales Market Share by Company (2018-2020)
3.2 Global Celecoxib Revenue Market Share by Company
3.2.1 Global Celecoxib Revenue by Company (2018-2020)
3.2.2 Global Celecoxib Revenue Market Share by Company (2018-2020)
3.3 Global Celecoxib Sale Price by Company
3.4 Global Celecoxib Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Celecoxib Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Celecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Celecoxib by Regions
4.1 Celecoxib by Regions
4.2 Americas Celecoxib Consumption Growth
4.3 APAC Celecoxib Consumption Growth
4.4 Europe Celecoxib Consumption Growth
4.5 Middle East & Africa Celecoxib Consumption Growth

5 Americas
5.1 Americas Celecoxib Consumption by Countries
5.1.1 Americas Celecoxib Consumption by Countries (2015-2020)
5.1.2 Americas Celecoxib Value by Countries (2015-2020)
5.2 Americas Celecoxib Consumption by Type
5.3 Americas Celecoxib Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Celecoxib Consumption by Regions
6.1.1 APAC Celecoxib Consumption by Regions (2015-2020)
6.1.2 APAC Celecoxib Value by Regions (2015-2020)
6.2 APAC Celecoxib Consumption by Type
6.3 APAC Celecoxib Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Celecoxib by Countries
7.1.1 Europe Celecoxib Consumption by Countries (2015-2020)
7.1.2 Europe Celecoxib Value by Countries (2015-2020)
7.2 Europe Celecoxib Consumption by Type
7.3 Europe Celecoxib Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Celecoxib by Countries
8.1.1 Middle East & Africa Celecoxib Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Celecoxib Value by Countries (2015-2020)
8.2 Middle East & Africa Celecoxib Consumption by Type
8.3 Middle East & Africa Celecoxib Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Celecoxib Distributors
10.3 Celecoxib Customer

11 Global Celecoxib Market Forecast
11.1 Global Celecoxib Consumption Forecast (2021-2025)
11.2 Global Celecoxib Forecast by Regions
11.2.1 Global Celecoxib Forecast by Regions (2021-2025)
11.2.2 Global Celecoxib Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Celecoxib Forecast by Type
11.8 Global Celecoxib Forecast by Application

12 Key Players Analysis
12.1 Pfizer Inc
12.1.1 Company Information
12.1.2 Celecoxib Product Offered
12.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Inc Latest Developments
12.2 Teva
12.2.1 Company Information
12.2.2 Celecoxib Product Offered
12.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Teva Latest Developments
12.3 Apotex
12.3.1 Company Information
12.3.2 Celecoxib Product Offered
12.3.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Apotex Latest Developments
12.4 Lupin
12.4.1 Company Information
12.4.2 Celecoxib Product Offered
12.4.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Lupin Latest Developments
12.5 Mylan
12.5.1 Company Information
12.5.2 Celecoxib Product Offered
12.5.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mylan Latest Developments
12.6 Hengrui Medicine
12.6.1 Company Information
12.6.2 Celecoxib Product Offered
12.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Hengrui Medicine Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Celecoxib Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 50mg
Table 5. Major Players of 100mg
Table 6. Major Players of 200mg
Table 7. Major Players of 400mg
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Celecoxib Consumption Market Share by Type (2015-2020)
Table 10. Global Celecoxib Revenue by Type (2015-2020) ($ million)
Table 11. Global Celecoxib Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Celecoxib Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Celecoxib Consumption Market Share by Application (2015-2020)
Table 15. Global Celecoxib Value by Application (2015-2020)
Table 16. Global Celecoxib Value Market Share by Application (2015-2020)
Table 17. Global Celecoxib Sale Price by Application (2015-2020)
Table 18. Global Celecoxib Sales by Company (2017-2019) (K Units)
Table 19. Global Celecoxib Sales Market Share by Company (2017-2019)
Table 20. Global Celecoxib Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Celecoxib Revenue Market Share by Company (2017-2019)
Table 22. Global Celecoxib Sale Price by Company (2017-2019)
Table 23. Global Celecoxib Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Celecoxib Products Offered
Table 25. Celecoxib Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Celecoxib Consumption by Regions 2015-2020 (K Units)
Table 27. Global Celecoxib Consumption Market Share by Regions 2015-2020
Table 28. Global Celecoxib Value by Regions 2015-2020 ($ Millions)
Table 29. Global Celecoxib Value Market Share by Regions 2015-2020
Table 30. Americas Celecoxib Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Celecoxib Consumption Market Share by Countries (2015-2020)
Table 32. Americas Celecoxib Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Celecoxib Value Market Share by Countries (2015-2020)
Table 34. Americas Celecoxib Consumption by Type (2015-2020) (K Units)
Table 35. Americas Celecoxib Consumption Market Share by Type (2015-2020)
Table 36. Americas Celecoxib Consumption by Application (2015-2020) (K Units)
Table 37. Americas Celecoxib Consumption Market Share by Application (2015-2020)
Table 38. APAC Celecoxib Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Celecoxib Consumption Market Share by Countries (2015-2020)
Table 40. APAC Celecoxib Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Celecoxib Value Market Share by Regions (2015-2020)
Table 42. APAC Celecoxib Consumption by Type (2015-2020) (K Units)
Table 43. APAC Celecoxib Consumption Market Share by Type (2015-2020)
Table 44. APAC Celecoxib Consumption by Application (2015-2020) (K Units)
Table 45. APAC Celecoxib Consumption Market Share by Application (2015-2020)
Table 46. Europe Celecoxib Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Celecoxib Consumption Market Share by Countries (2015-2020)
Table 48. Europe Celecoxib Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Celecoxib Value Market Share by Countries (2015-2020)
Table 50. Europe Celecoxib Consumption by Type (2015-2020) (K Units)
Table 51. Europe Celecoxib Consumption Market Share by Type (2015-2020)
Table 52. Europe Celecoxib Consumption by Application (2015-2020) (K Units)
Table 53. Europe Celecoxib Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Celecoxib Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Celecoxib Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Celecoxib Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Celecoxib Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Celecoxib Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Celecoxib Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Celecoxib Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Celecoxib Consumption Market Share by Application (2015-2020)
Table 62. Celecoxib Distributors List
Table 63. Celecoxib Customer List
Table 64. Global Celecoxib Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Celecoxib Consumption Market Forecast by Regions
Table 66. Global Celecoxib Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Celecoxib Value Market Share Forecast by Regions
Table 68. Global Celecoxib Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Celecoxib Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Celecoxib Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Celecoxib Value Market Share Forecast by Type (2021-2025)
Table 72. Global Celecoxib Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Celecoxib Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Celecoxib Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Celecoxib Value Market Share Forecast by Application (2021-2025)
Table 76. Pfizer Inc Product Offered
Table 77. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Pfizer Inc Main Business
Table 79. Pfizer Inc Latest Developments
Table 80. Pfizer Inc Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Product Offered
Table 82. Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Teva Main Business
Table 84. Teva Latest Developments
Table 85. Teva Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 86. Apotex Product Offered
Table 87. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Apotex Main Business
Table 89. Apotex Latest Developments
Table 90. Apotex Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 91. Lupin Product Offered
Table 92. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Lupin Main Business
Table 94. Lupin Latest Developments
Table 95. Lupin Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 96. Mylan Product Offered
Table 97. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Mylan Main Business
Table 99. Mylan Latest Developments
Table 100. Mylan Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 101. Hengrui Medicine Product Offered
Table 102. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Hengrui Medicine Main Business
Table 104. Hengrui Medicine Latest Developments
Table 105. Hengrui Medicine Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Celecoxib
Figure 2. Celecoxib Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Celecoxib Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Celecoxib Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 50mg
Figure 7. Product Picture of 100mg
Figure 8. Product Picture of 200mg
Figure 9. Product Picture of 400mg
Figure 10. Global Celecoxib Consumption Market Share by Type (2015-2020)
Figure 11. Global Celecoxib Value Market Share by Type (2015-2020)
Figure 12. Celecoxib Consumed in Rheumatoid arthritis
Figure 13. Global Celecoxib Market: Rheumatoid arthritis (2015-2020) (K Units)
Figure 14. Global Celecoxib Market: Rheumatoid arthritis (2015-2020) ($ Millions)
Figure 15. Celecoxib Consumed in osteoarthritis
Figure 16. Global Celecoxib Market: osteoarthritis (2015-2020) (K Units)
Figure 17. Global Celecoxib Market: osteoarthritis (2015-2020) ($ Millions)
Figure 18. Celecoxib Consumed in Acute pain
Figure 19. Global Celecoxib Market: Acute pain (2015-2020) (K Units)
Figure 20. Global Celecoxib Market: Acute pain (2015-2020) ($ Millions)
Figure 21. Celecoxib Consumed in Musculoskeletal pain
Figure 22. Global Celecoxib Market: Musculoskeletal pain (2015-2020) (K Units)
Figure 23. Global Celecoxib Market: Musculoskeletal pain (2015-2020) ($ Millions)
Figure 24. Celecoxib Consumed in Other diseases
Figure 25. Global Celecoxib Market: Other diseases (2015-2020) (K Units)
Figure 26. Global Celecoxib Market: Other diseases (2015-2020) ($ Millions)
Figure 27. Global Celecoxib Consumption Market Share by Application (2015-2020)
Figure 28. Global Celecoxib Value Market Share by Application (2015-2020)
Figure 29. Global Celecoxib Sales Market Share by Company in 2017
Figure 30. Global Celecoxib Sales Market Share by Company in 2019
Figure 31. Global Celecoxib Revenue Market Share by Company in 2017
Figure 32. Global Celecoxib Revenue Market Share by Company in 2019
Figure 33. Global Celecoxib Sale Price by Company in 2019
Figure 34. Global Celecoxib Consumption Market Share by Regions 2015-2020
Figure 35. Global Celecoxib Value Market Share by Regions 2015-2020
Figure 36. Americas Celecoxib Consumption 2015-2020 (K Units)
Figure 37. Americas Celecoxib Value 2015-2020 ($ Millions)
Figure 38. APAC Celecoxib Consumption 2015-2020 (K Units)
Figure 39. APAC Celecoxib Value 2015-2020 ($ Millions)
Figure 40. Europe Celecoxib Consumption 2015-2020 (K Units)
Figure 41. Europe Celecoxib Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Celecoxib Consumption 2015-2020 (K Units)
Figure 43. Middle East & Africa Celecoxib Value 2015-2020 ($ Millions)
Figure 44. Americas Celecoxib Consumption Market Share by Countries in 2019
Figure 45. Americas Celecoxib Value Market Share by Countries in 2019
Figure 46. Americas Celecoxib Consumption Market Share by Type in 2019
Figure 47. Americas Celecoxib Consumption Market Share by Application in 2019
Figure 48. United States Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 49. United States Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 51. Canada Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 53. Mexico Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Celecoxib Consumption Market Share by Countries in 2019
Figure 55. APAC Celecoxib Value Market Share by Regions in 2019
Figure 56. APAC Celecoxib Consumption Market Share by Type in 2019
Figure 57. APAC Celecoxib Consumption Market Share by Application in 2019
Figure 58. China Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 59. China Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 61. Japan Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 63. Korea Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 65. Southeast Asia Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 66. India Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 67. India Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 69. Australia Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Celecoxib Consumption Market Share by Countries in 2019
Figure 71. Europe Celecoxib Value Market Share by Countries in 2019
Figure 72. Europe Celecoxib Consumption Market Share by Type in 2019
Figure 73. Europe Celecoxib Consumption Market Share by Application in 2019
Figure 74. Germany Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 75. Germany Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 76. France Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 77. France Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 78. UK Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 79. UK Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 81. Italy Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 83. Russia Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Celecoxib Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Celecoxib Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Celecoxib Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Celecoxib Consumption Market Share by Application in 2019
Figure 88. Egypt Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 89. Egypt Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 91. South Africa Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 93. Israel Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 95. Turkey Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Celecoxib Consumption Growth 2015-2020 (K Units)
Figure 97. GCC Countries Celecoxib Value Growth 2015-2020 ($ Millions)
Figure 98. Global Celecoxib Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 99. Global Celecoxib Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Celecoxib Consumption 2021-2025 (K Units)
Figure 101. Americas Celecoxib Value 2021-2025 ($ Millions)
Figure 102. APAC Celecoxib Consumption 2021-2025 (K Units)
Figure 103. APAC Celecoxib Value 2021-2025 ($ Millions)
Figure 104. Europe Celecoxib Consumption 2021-2025 (K Units)
Figure 105. Europe Celecoxib Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Celecoxib Consumption 2021-2025 (K Units)
Figure 107. Middle East & Africa Celecoxib Value 2021-2025 ($ Millions)
Figure 108. United States Celecoxib Consumption 2021-2025 (K Units)
Figure 109. United States Celecoxib Value 2021-2025 ($ Millions)
Figure 110. Canada Celecoxib Consumption 2021-2025 (K Units)
Figure 111. Canada Celecoxib Value 2021-2025 ($ Millions)
Figure 112. Mexico Celecoxib Consumption 2021-2025 (K Units)
Figure 113. Mexico Celecoxib Value 2021-2025 ($ Millions)
Figure 114. Brazil Celecoxib Consumption 2021-2025 (K Units)
Figure 115. Brazil Celecoxib Value 2021-2025 ($ Millions)
Figure 116. China Celecoxib Consumption 2021-2025 (K Units)
Figure 117. China Celecoxib Value 2021-2025 ($ Millions)
Figure 118. Japan Celecoxib Consumption 2021-2025 (K Units)
Figure 119. Japan Celecoxib Value 2021-2025 ($ Millions)
Figure 120. Korea Celecoxib Consumption 2021-2025 (K Units)
Figure 121. Korea Celecoxib Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Celecoxib Consumption 2021-2025 (K Units)
Figure 123. Southeast Asia Celecoxib Value 2021-2025 ($ Millions)
Figure 124. India Celecoxib Consumption 2021-2025 (K Units)
Figure 125. India Celecoxib Value 2021-2025 ($ Millions)
Figure 126. Australia Celecoxib Consumption 2021-2025 (K Units)
Figure 127. Australia Celecoxib Value 2021-2025 ($ Millions)
Figure 128. Germany Celecoxib Consumption 2021-2025 (K Units)
Figure 129. Germany Celecoxib Value 2021-2025 ($ Millions)
Figure 130. France Celecoxib Consumption 2021-2025 (K Units)
Figure 131. France Celecoxib Value 2021-2025 ($ Millions)
Figure 132. UK Celecoxib Consumption 2021-2025 (K Units)
Figure 133. UK Celecoxib Value 2021-2025 ($ Millions)
Figure 134. Italy Celecoxib Consumption 2021-2025 (K Units)
Figure 135. Italy Celecoxib Value 2021-2025 ($ Millions)
Figure 136. Russia Celecoxib Consumption 2021-2025 (K Units)
Figure 137. Russia Celecoxib Value 2021-2025 ($ Millions)
Figure 138. Spain Celecoxib Consumption 2021-2025 (K Units)
Figure 139. Spain Celecoxib Value 2021-2025 ($ Millions)
Figure 140. Egypt Celecoxib Consumption 2021-2025 (K Units)
Figure 141. Egypt Celecoxib Value 2021-2025 ($ Millions)
Figure 142. South Africa Celecoxib Consumption 2021-2025 (K Units)
Figure 143. South Africa Celecoxib Value 2021-2025 ($ Millions)
Figure 144. Israel Celecoxib Consumption 2021-2025 (K Units)
Figure 145. Israel Celecoxib Value 2021-2025 ($ Millions)
Figure 146. Turkey Celecoxib Consumption 2021-2025 (K Units)
Figure 147. Turkey Celecoxib Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Celecoxib Consumption 2021-2025 (K Units)
Figure 149. GCC Countries Celecoxib Value 2021-2025 ($ Millions)
Figure 150. Pfizer Inc Celecoxib Market Share (2018-2020)
Figure 151. Teva Celecoxib Market Share (2018-2020)
Figure 152. Apotex Celecoxib Market Share (2018-2020)
Figure 153. Lupin Celecoxib Market Share (2018-2020)
Figure 154. Mylan Celecoxib Market Share (2018-2020)
Figure 155. Hengrui Medicine Celecoxib Market Share (2018-2020)
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs